New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 18, 2012
12:28 EDTGTAT, SWHC, GALE, NLSN, RGR, ARBOn The Fly: Midday Wrap
Stocks on Wall Street were markedly higher at midday as optimism surrounding the fiscal cliff negotiations continues to spur buying. Investors have been paying less attention to recent economic reports to focus instead on the fiscal cliff, as demonstrated by the NAHB Housing Market index prompting little reaction, despite its highest reading since April 2006. The averages moved to session highs following comments from both sides of Washington's negotiating table that they hope a deal can still be reached... ECONOMIC EVENTS: In the U.S., the National Association of Home Builders index of builder confidence increased to 47, as was forecast. Also, the current-account deficit in the U.S. narrowed in the third quarter to $107.5B from a $118.1B shortfall in the prior quarter. Economists expected the deficit would narrow to about $103B... COMPANY NEWS: Gunmakers Smith & Wesson (SWHC) and Sturm, Ruger (RGR) continued their recent weakness as a Wall Street Journal cover story highlighted some of the ways American companies are distancing themselves from guns and their makers amid a public outcry in the aftermath of last week's tragedy in Connecticut. Among the recent developments underscored was the decision from private equity firm Cerberus Capital Management to put gunmaker Freedom Group up for sale... MAJOR MOVERS: Among the notable gainers was Arbitron (ARB), up over 23% after agreeing to be bought by Nielsen (NLSN) for $48 per share in cash. Shares of acquirer Nielsen also rose about 3%. Among the noteworthy losers was Galena Biopharma (GALE), down 17% after it sold common stock and warrants to purchase additional shares in a public offering. Also lower was GT Advanced Technologies (GTAT), which was downgraded at Raymond James and Stifel Nicolaus and saw its shares slide more than 12% after issuing guidance well below Street expectations... INDICES: Near noon, the Dow was up 83.20, or 0.63%, to 13,318.59; the Nasdaq was up 33.89, or 1.13%, to 3,044.49; and the S&P 500 was up 11.60, or 0.81%, to 1,441.96.
News For ARB;NLSN;SWHC;RGR;GALE;GTAT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 16, 2014
06:16 EDTGTATGT Advanced's settlement with Apple approved by bankruptcy court, WSJ reports
Subscribe for More Information
December 11, 2014
10:24 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
09:43 EDTNLSNNielsen 20M share Spot Secondary priced at $43.00
The deal range was $43.00-$43.25. Citigroup acted as sole book running manager for the offering.
08:40 EDTGALEGalena presents HER2 screening data results from NeuVax Phase 3 clinical trial
Galena Biopharma announced that initial immunohistochemistry, or IHC, screening data from the NeuVax Phase 3 PRESENT, or Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low to Intermediate HER2 Expression with NeuVax Treatment, trial was presented at the 2014 San Antonio Breast Cancer Symposium, or SABCS. The poster, entitled, "HER2 Discordant Results in Local vs. Central Testing in the Phase 3 Nelipepimut-S Trial and Implementation of Leica Bond Oracle HER2 Immunohistochemistry System for Low and Intermediate Levels of HER2 Protein Expression as a Companion Diagnostic," demonstrated that with the implementation of the Leica Bond Oracle HER2 IHC assay, preliminary limited data indicated additional patients met HER2 eligibility for PRESENT and the assay identified more precisely patients at HER2 1+ and 2+. As part of the PRESENT trial, Galena has implemented central laboratory testing for all potential patients to confirm validated and robust entry criteria, and ensure the enrollment of the targeted patient population. To improve accuracy and specificity for the HER2 1+ and 2+ status testing, and develop a companion diagnostic for NeuVax, the Leica Bond Oracle HER2 IHC system has been incorporated as central HER2 IHC screening for the PRESENT study.
December 10, 2014
18:31 EDTNLSNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Restoration Hardware (RH), up 5.9%... Casey's General Stores (CASY), up 1.6%. ALSO HIGHER: Walgreen (WAG), up 1.7% after CEO Greg Wasson announces intention to retire after Alliance merger. DOWN AFTER EARNINGS: Wet Seal (WTSL), down 38.9%... Lakeland Industries (LAKE), down 8.2%... Men's Wearhouse (MW), down fractionally. ALSO LOWER: Burlington Stores (BURL), down 1.4% after filing to sell 8M shares of common stock for holders... Nielsen (NLSN), down 1.9% after filing to sell 20M shares of common stock for holders.
16:50 EDTNLSNNielsen files to sell 20M shares of common stock for holders
Subscribe for More Information
10:20 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
December 8, 2014
10:20 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
09:20 EDTGALEOn The Fly: Pre-market Movers
Subscribe for More Information
07:08 EDTGALEGalena GALE-401 Phase 1 results show reduced platelet counts, tolerable safety
Subscribe for More Information
December 5, 2014
10:40 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
07:27 EDTNLSNNielsen to host analyst meeting
Subscribe for More Information
December 4, 2014
18:34 EDTSWHCOn The Fly: After Hours Movers
Subscribe for More Information
16:15 EDTSWHCSmith & Wesson sees FY15 EPS 66c-70c, consensus 89c
Subscribe for More Information
16:13 EDTSWHCSmith & Wesson sees Q3 EPS 9c-11c, may not compare to consensus 20c
Subscribe for More Information
16:12 EDTSWHCSmith & Wesson reports Q2 EPS 9c, consensus 7c
Subscribe for More Information
15:18 EDTSWHCNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Cooper Companies (COO), consensus $2.03; ULTA Salon (ULTA), consensus 84c; American Eagle Outfitters (AEO), consensus 22c; Five Below (FIVE), consensus 6c; Ambarella (AMBA), consensus 54c; Finisar (FNSR), consensus 25c; Smith & Wesson (SWHC), consensus 7c.
December 3, 2014
10:00 EDTNLSNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTNLSNNielsen upgraded to Buy following correction in shares at Needham
Subscribe for More Information
06:46 EDTNLSNNielsen upgraded to Buy from Hold at Needham
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use